+62.6%
GSK vs CASY
+154.1%
-91.5%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CASY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | -0.3% | +0.1% | -0.1% |
| 7D | +1.7% | +1.1% | +0.6% | +1.5% |
| 30D | +7.0% | +8.7% | -1.7% | +6.3% |
| 3M | -2.7% | -17.3% | +14.7% | -1.1% |
| 6M | +1.4% | -19.7% | +21.2% | +3.2% |
| YTD | +5.3% | +24.8% | -19.5% | +1.8% |
| 1Y | +10.6% | +31.9% | -21.3% | +6.1% |
| 3Y | +62.6% | +155.4% | -92.8% | +46.4% |
| All | +62.6% | +154.1% | -91.5% | +46.4% |
Cumulative growth
Daily Returns
Daily percentage return beside CASY.
Daily Out/Under-Performance
Portfolio return minus CASY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CASY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CASY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling